PF-Atlas › Clinical Trials › NCT01262001

Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis

FG-3019 · Phase 2

Registry ID

NCT01262001

Phase

Phase 2

Status

Completed

Drug / intervention

FG-3019

Sponsor

Kyntra Bio

Start

2011-03

About this trial

FG-3019 is evaluated in NCT01262001, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Kyntra Bio. Current status: Completed.

View NCT01262001 on ClinicalTrials.gov →

Explore related

All FG-3019 trials All IPF trials

Related trials

FG-3019 — NCT00074698

Medical disclaimer. This page summarizes public trial data for NCT01262001 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.